March 2024: On March 14, 2024, the Court held an initial case management conference to discuss, among other things, various organizational and procedural issues, such as leadership structure for the plaintiffs, plaintiff fact sheets about the different GLP-1 receptor drugs that may have been taken and the alleged injuries that plaintiffs claim to have suffered as a result of taking the medications
RoshanravanNMahdaviRAlizadehEGhavamiASaadatYRAlamdariNMet alThe effects of sodium butyrate and inulin supplementation on angiotensin signaling pathway via promotion of Akkermansia muciniphila abundance in type 2 diabetes
To provide a specific dosage of a particular ingredient
The latest study shows absorption and immune cell empowerment
Sharp, stabbing, or electric shock pain that shoots down the leg with movement, coughing, or sneezing